These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021. Ghaznavi C; Eguchi A; Suu Lwin K; Yoneoka D; Tanoue Y; Kumar Rauniyar S; Horiuchi S; Hashizume M; Nomura S Vaccine; 2023 Jun; 41(28):4151-4157. PubMed ID: 37246068 [TBL] [Abstract][Full Text] [Related]
24. Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-up Efforts for Serbia. Burgess C; Lisul B; Pawaskar M; Petigara T; Murtagh J; Kanazir M; Loncarevic G; Carias C Pediatr Infect Dis J; 2024 Oct; 43(10):1011-1017. PubMed ID: 39105529 [TBL] [Abstract][Full Text] [Related]
25. Measles control in Sub-Saharan Africa: South Africa as a case study. Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581 [TBL] [Abstract][Full Text] [Related]
27. Global Routine Vaccination Coverage, 2018. Peck M; Gacic-Dobo M; Diallo MS; Nedelec Y; Sodha SV; Wallace AS MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(42):937-942. PubMed ID: 31647786 [TBL] [Abstract][Full Text] [Related]
28. Progress toward measles mortality reduction and elimination--Eastern Mediterranean Region, 1997-2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):262-7. PubMed ID: 18340334 [TBL] [Abstract][Full Text] [Related]
29. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010. Gaafar T; Moshni E; Lievano F J Infect Dis; 2003 May; 187 Suppl 1():S164-71. PubMed ID: 12721909 [TBL] [Abstract][Full Text] [Related]
30. Trend of measles-rubella vaccination coverage and impact on measles epidemiology in the Savannah Region, Ghana; 2018-2022: A secondary data analysis. Rockson Adjei M; Longsignikuu A; Saeed Iddris I; Nang Suuri T; Asamoah B; Okoye M; Vanessa Baafi J; Kubio C; Ohene SA; Grobusch MP Vaccine; 2024 Mar; 42(8):1910-1917. PubMed ID: 38365480 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China. Hu Y; Chen Y; Wang Y; Liang H Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094 [TBL] [Abstract][Full Text] [Related]
32. Global vaccine coverage and childhood survival estimates: 1990-2019. Zhang H; Patenaude B; Zhang H; Jit M; Fang H Bull World Health Organ; 2024 Apr; 102(4):276-287. PubMed ID: 38562199 [TBL] [Abstract][Full Text] [Related]
34. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria. Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705 [TBL] [Abstract][Full Text] [Related]
35. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo. Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000 [TBL] [Abstract][Full Text] [Related]
36. Factors affecting immunization coverage levels in a district of India. Balraj V; Mukundan S; Samuel R; John TJ Int J Epidemiol; 1993 Dec; 22(6):1146-53. PubMed ID: 8144298 [TBL] [Abstract][Full Text] [Related]
37. Impact of measles supplementary immunization activities on reaching children missed by routine programs. Portnoy A; Jit M; Helleringer S; Verguet S Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680 [TBL] [Abstract][Full Text] [Related]
38. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis. Castrejon MM; Leal I; de Jesus Pereira Pinto T; Guzmán-Holst A Hum Vaccin Immunother; 2022 Nov; 18(6):2102353. PubMed ID: 36084255 [TBL] [Abstract][Full Text] [Related]